DJIA 17,712.66 34.43 0.19%
NASDAQ 4,891.22 27.86 0.57%
S&P 500 2,061.02 4.87 0.24%
market minute promo

Acorda Therapeutics, Inc. (NASDAQ: ACOR)

34.20 1.26 (3.83%)

REAL-TIME: Last trade at


company name or ticker

Recent Quotes

ACOR $34.20 3.83%
1D 1W 3M 6M 1Y 2Y 3Y
Today's Open $32.80
Previous Close $32.94
Daily Range $32.71 - $34.35
52-Week Range $28.26 - $45.45
Market Cap $1.5B
P/E Ratio 78.43
Dividend (Yield) $0.00 (0.0%)
Volume 585,306
Average Daily Volume 785,762
Current FY EPS $0.20

Sector

Healthcare

Industry

Drug Makers

Acorda Therapeutics, Inc. (ACOR) Description

A commercial-stage biopharmaceutical company dedicated to the identification, development & commercialization of novel therapies that improve neurological function in people with multiple sclerosis, spinal cord injury and other disorders of the CNS. Website: http://www.acorda.com/

News & Commentary Rss Feed

Forget MannKind Corporation; Here Are 3 Better Biotech Stocks

Although MannKind is launching Afrezza this year, our Motley Fool experts think these three stocks may be better buys.

Orexigen's Obesity Drug Mysimba Gains European Approval - Analyst Blog

Avalanche Biotechnologies (AAVL) Crumbles: Stock Falls by 6.4% - Tale of the Tape

Sanofi Reveals Cerdelga Data, FDA OK's Quadracel Vaccine - Analyst Blog

Sanofi Reveals Cerdelga Data, FDA OK's Quadracel Vaccine - Analyst Blog

Merck in $10B Buyback; Keytruda Tops Melanoma Study - Analyst Blog

The Zacks Analyst Blog Highlights: HSBC Holdings, Goldman Sachs, Acorda Therapeutics, Biogen Idec an

The Zacks Analyst Blog Highlights: HSBC Holdings, Goldman Sachs, Acorda Therapeutics, Biogen Idec and Ross Stores - Press Releases

OvaScience, Inc. (OVAS) in Focus: Stock Surges 12.2% - Tale of the Tape

Vertex Falls on Disappointing Kalydeco+VX-661 Combo Data - Analyst Blog

2 Stocks to Beat the Dollar's Volatile Run - Analyst Blog

2 Stocks to Beat the Dollar's Volatile Run - Analyst Blog

Biogen Gains on Positive Alzheimer's Drug Interim Results - Analyst Blog

Celgene Presents Efficacy, Safety Data on Otezla - Analyst Blog

See More ACOR News...

ACOR's Top Competitors

ACOR $34.20 (3.83%)
Current stock: ACOR
AMGN $162.59 (1.27%)
Current stock: AMGN
GILD $101.00 (-0.07%)
Current stock: GILD
BIIB $429.87 (0.22%)
Current stock: BIIB